Literature DB >> 25446350

Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.

M L Perreault1, M Y F Shen1, T Fan1, S R George2.   

Abstract

The dopamine D1 and D2 receptors form the D1-D2 receptor heteromer in a subset of neurons and couple to the Gq protein to regulate intracellular calcium signaling. In the present study the effect of D1-D2 heteromer activation and disruption on neuronal activation in the rat brain was mapped. This was accomplished using the dopamine agonist SKF 83959 to activate the D1-D2 heteromer in combination with a TAT-D1 disrupting peptide we developed, and which has been shown to disrupt the D1/D2 receptor interaction and antagonize D1-D2 heteromer-induced cell signaling and behavior. Acute SKF 83959 administration to rats induced significant c-fos expression in the nucleus accumbens that was significantly inhibited by TAT-D1 pretreatment. No effects of SKF 83959 were seen in caudate putamen. D1-D2 heteromer disruption by TAT-D1 did not have any effects in any striatal subregions, but induced significant c-fos immunoreactivity in a number of cortical regions including the orbitofrontal cortex, prelimbic and infralimbic cortices and piriform cortex. The induction of c-fos by TAT-D1 was also evident in the anterior olfactory nucleus, as well as the lateral habenula and thalamic nuclei. These findings show for the first time that the D1-D2 heteromer can differentially regulate c-fos expression in a region-dependent manner either through its activation or through tonic inhibition of neuronal activity.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  c-fos; cortex; dopamine D1-D2 heteromer; lateral habenula; nucleus accumbens

Mesh:

Substances:

Year:  2014        PMID: 25446350      PMCID: PMC4467353          DOI: 10.1016/j.neuroscience.2014.11.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

1.  Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects.

Authors:  Lin Pei; Shupeng Li; Min Wang; Mustansir Diwan; Hymie Anisman; Paul J Fletcher; José N Nobrega; Fang Liu
Journal:  Nat Med       Date:  2010-11-28       Impact factor: 53.440

2.  Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.

Authors:  A M Deveney; J L Waddington
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.

Authors:  Yun-Ping Deng; Wan-Long Lei; Anton Reiner
Journal:  J Chem Neuroanat       Date:  2006-08-17       Impact factor: 3.052

4.  Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase.

Authors:  R P Downes; J L Waddington
Journal:  Eur J Pharmacol       Date:  1993-03-30       Impact factor: 4.432

5.  A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.

Authors:  K E Culver; J M Rosenfeld; H Szechtman
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

6.  Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.

Authors:  Michelle Zenko; Yongyong Zhu; Eliyahu Dremencov; Wei Ren; Lin Xu; Xia Zhang
Journal:  J Neurosci Res       Date:  2011-05-06       Impact factor: 4.164

7.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain.

Authors:  S J Boyson; P McGonigle; P B Molinoff
Journal:  J Neurosci       Date:  1986-11       Impact factor: 6.167

8.  D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.

Authors:  M L Paul; A M Graybiel; J C David; H A Robertson
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

9.  Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.

Authors:  Samuel P Lee; Christopher H So; Asim J Rashid; George Varghese; Regina Cheng; A José Lança; Brian F O'Dowd; Susan R George
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

10.  Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2.

Authors:  Melissa L Perreault; Theresa Fan; Mohammed Alijaniaram; Brian F O'Dowd; Susan R George
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more
  8 in total

1.  Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.

Authors:  Jennie L Conroy; R Benjamin Free; David R Sibley
Journal:  ACS Chem Neurosci       Date:  2015-02-20       Impact factor: 4.418

2.  Localization of the dopamine receptors of types 1 and 2 on the bodies of POMC-expressing neurons of the arcuate nucleus of the hypothalamus in mice and rats.

Authors:  I V Romanova; A L Mikhrina; A O Shpakov
Journal:  Dokl Biol Sci       Date:  2017-04-21

3.  Chronic hypothalamic-pituitary-adrenal axis disruption alters glutamate homeostasis and neural responses to stress in male C57Bl6/N mice.

Authors:  Scott A Kinlein; Naomi K Wallace; Marina I Savenkova; Ilia N Karatsoreos
Journal:  Neurobiol Stress       Date:  2022-06-05

4.  The Leptin, Dopamine and Serotonin Receptors in Hypothalamic POMC-Neurons of Normal and Obese Rodents.

Authors:  Irina V Romanova; Kira V Derkach; Anastasiya L Mikhrina; Ivan B Sukhov; Elena V Mikhailova; Alexander O Shpakov
Journal:  Neurochem Res       Date:  2018-02-03       Impact factor: 3.996

Review 5.  Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.

Authors:  Amy F T Arnsten; Ragy R Girgis; David L Gray; Richard B Mailman
Journal:  Biol Psychiatry       Date:  2016-01-18       Impact factor: 13.382

6.  The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Irene Reyes-Resina; Gemma Navarro
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 7.  The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB2 Receptors.

Authors:  Rafael Franco; Paula Morales; Gemma Navarro; Nadine Jagerovic; Irene Reyes-Resina
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

8.  To Do or Not to Do: Dopamine, Affordability and the Economics of Opportunity.

Authors:  Jeff A Beeler; Devry Mourra
Journal:  Front Integr Neurosci       Date:  2018-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.